Johnson and Johnson 2005 Annual Report Download - page 19

Download and view the complete annual report

Please find page 19 of the 2005 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

REACHING MORE PEOPLE, SERVING MORE HEALTH NEEDS. PAGE 17
From heritage brands to new categories, research-driven products
contribute to new dimensions in health and personal care.
were highlighted, including Feverfew PFE™ for sensitive
skin, retinol for anti-aging, soy for even tone and texture,
and oatmeal for relief of dry skin. Centocor also presented
Phase III data for REMICADE®(infliximab) that demon-
strates rapid and significant improvement of plaque
psoriasis, a disease that affects as many as 4.5 million
people in the U.S. As the skin care category evolves
toward advanced cosmetic applications and therapies
for diseases and disorders, the scientific expertise
across Johnson & Johnson dermatological companies
provides a solid foundation for helping consumers
achieve and maintain healthy, beautiful skin.
As the leader in ACTIVE NATURALS™, AVEENO® utilizes
ingredients derived from nature to optimize skin’s
health and beauty. In 2005, AVEENO®brought new
natural technologies to facial care and expanded into
lip care and sun care. To address the needs of women
with sensitive skin, the new AVEENO®Ultra-Calming
line captures the benefits of naturally calming Feverfew,
an ingredient related to chamomile, and is clinically
proven to visibly reduce redness in as little as one week.
AVEENO®ESSENTIAL MOISTURE™ Lip Conditioner
with SPF15 and AVEENO®CONTINUOUS PROTECTION
Sunblock Lotion are also among the latest introductions
to the AVEENO®line. AVEENO®has been recommended
by dermatologists and pediatricians for 60 years.
Introduced in China in late 2004, the NEUTROGENA® brand
continues a successful expansion, bringing skin care ben-
efits and greater choices to more consumers in major
cities. NEUTROGENA®acne, facial cleanser and sun
protection products are number one dermatologist-
recommended, based on surveys in key launch cities.
SPLENDA® Brown Sugar
Blend from McNeil
Nutritionals, LLC is a
first-of-its-kind reduced
calorie brown sugar
product. This innova-
tive product offers a
proprietary blend of brown sugar and SPLENDA®Brand
Sweetener, or sucralose. A serving of SPLENDA®Brown
Sugar Blend has half the calories, half the sugar, and
half the carbohydrates of brown sugar and can be used
anywhere brown sugar is used. This new addition to
the SPLENDA®Brand family of products provides yet
another great tasting way to reduce sugar calories in a
greater variety of places.
The science-based skin care technologies from Johnson
& Johnson Consumer Products Company Division
of Johnson & Johnson Consumer Companies, Inc., the
OrthoNeutrogena division of Ortho-McNeil Pharma-
ceutical, Inc., and Centocor, Inc. were showcased at
the 63rd Annual Meeting of the American Academy
of Dermatology in 2005. Proprietary dermatological
technologies and applications in addressing key needs